FDA NDC Directory · JSON-LD · Markdown
NDC 62332-724 · HUMAN PRESCRIPTION DRUG · CAPSULE, EXTENDED RELEASE
| Labeler / Manufacturer | Alembic Pharmaceuticals Inc. |
|---|---|
| Marketing category | Abbreviated NDA (generic) · App ANDA216967 |
| Dosage form / route | CAPSULE, EXTENDED RELEASE · ORAL |
| Active ingredients | MESALAMINE (.375 g/1) |
| Marketing started | 20221103 |
| Package count | 2 |
Source: openFDA. Public-domain (CC0).